Divis Laboratories - Future Generics


	Divi’s Labs earns an Income of Rs.649 crores for 9M of FY10


	Divis Labs earns an Income of Rs.445 crores in H1 of FY10


	Divi’s Labs earns an Income of Rs.218 crores in Q1


	Divi’s Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus

	Divi’s Labs PAT for 9 months grows by 21% to Rs.309 crores

	Divi’s Labs PAT for Q2 grows by 49% to Rs.135 crores

	Divi’s Labs PAT for Q1 grows by 45% to Rs.94 crores

	Divi’s Labs PAT for FY08 grows by 87% to Rs.348 crores

	Divi’s Labs PAT for Q3 grows by 216% to Rs.99 crores

	Divi’s Labs PAT for Q2 grows by 204% to Rs.91 crores

	Divi’s Labs PAT for Q1 grows by 153% to Rs.65 crores

	Divi’s Labs PAT for FY07 grows by 167% to Rs.186 crores

	Divi’s Labs Q3 total income grows by 38% to Rs.152 crores

	Divis successful US-FDA inspection for Unit II

	Divi’s Labs Q2 total income grows by 97% to Rs.165 crores.

	Divi's Labs Q1 total income grows by 142% at Rs.165 crores

	Divi's Laboratories earns a net of 70 crores on an income of Rs.392 crores in FY06

	Divi's gets nod for pharma SEZ

	Divis Laboratories earns a PBT of Rs.43 Crores in First-Half of FY06

	Divis Laboratories earns a total income of Rs.68 Crores in Q1 of FY06

	Divis Laboratories earns a total income of Rs.365 Crores in FY05

	Divis Laboratories earns a Net of Rs.105 Crores in Q3

	Divis Laboratories earns a PBT of Rs.45 Crores in First-Half of FY05

	Divis Laboratories earns a Net of Rs.14 Crores in Q1